UBS Group
WVE icon

UBS Group’s Wave Life Sciences WVE Stock Holding History

UBS Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$531K Buy
+91,400
New +$606K ﹤0.01% 6189
2026
Q1 		– Sell
-30,000
Closed -$510K – 11241
2025
Q4 		$510K Buy
+30,000
New +$305K ﹤0.01% 6078

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

UBS Group's WVE Position: Q2 2026 in Review

UBS Group reduced its Wave Life Sciences (WVE) stake by 6.3% in Q2 2026, selling an estimated $224K and leaving 505,237 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #4719.

UBS Group first reported a position in WVE in Q4 2015 and has held it in 43 quarters since. The position peaked at $5.17M in Q3 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • UBS Group held 505,237 shares of Wave Life Sciences worth $2.94M as of Q2 2026.
  • UBS Group sold 33,760 Wave Life Sciences shares in Q2 2026, an estimated $224K.
  • Wave Life Sciences made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4719 holding.
  • UBS Group first reported a position in Wave Life Sciences in Q4 2015 and has held it in 43 quarters since.
  • UBS Group's Wave Life Sciences position peaked at $5.17M in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.